2012-11-29

[DIV28M] Call for papers for Special Issue of Experimental and Clinical Psychopharmacology

Experimental and Clinical Psychopharmacology will publish a Special Issue focused on Psychopharmacology of Attention: The Impact of Drugs in an Age of Increased Distractions in October 2013.  The goal of this special issue is to highlight progress made during the past 15 years in understanding how licit and illicit drugs impact attention within the context of prevailing contemporary distractions. Topics such as distracted driving, social networking, animal and human models of multitasking, and attention-deficit/hyperactivity disorder are just a few of the areas of relevance to this special issue.   

Laboratories engaged in research in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this Special Issue. Please contact the Guest Editor, Dr. Anthony Liguori, or the Editor, Dr. Suzette Evans, directly (see below) with your topic, a draft title and a draft abstract before submitting your manuscript.  These will also us to create a dynamic and diverse issue on these topics.  Manuscripts should be submitted as usual through the APA Online Submission Portal, and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the Special Issue on Psychopharmacology of Attention. While we cannot guarantee that your submission will be accepted for inclusion in the final published special section, we hope that you will consider submitting a manuscript for this Special Issue. Manuscripts received no later than February 15, 2013 will be considered for inclusion in the Special Issue. 

Questions or inquiries about the Special Issue can be directed to the Guest Editor of the issue, Anthony Liguori, Ph.D., at aliguori@wakehealth.edu or the Editor, Suzette M. Evans, Ph.D., at se18@columbia.edu.

Suzette M. Evans, Ph.D.
Professor of Clinical Neuroscience and Research Scientist VI
Director of the Women's Research Center
Editor, Experimental and Clinical Psychopharmacology
Columbia University and the New York State Psychiatric Institute
1051 Riverside Drive
Unit 66, Room 3704
New York NY 10032

Voice: 212-543-5895
Fax: 212-543-6018


IMPORTANT NOTICE: This e-mail is meant only for the use of the intended

recipient. It may contain confidential information that is legally privileged

or otherwise protected by law. If you received this e-mail in error or from

someone who was not authorized to send it to you, you are strictly prohibited

from reviewing, using, disseminating, distributing or copying the e-mail. PLEASE

NOTIFY US IMMEDIATELY OF THE ERROR BY RETURN E-MAIL AND DELETE THIS MESSAGE FROM YOUR SYSTEM. Thank you for your cooperation.








2012-11-28

[DIV28M] APA Division 28 Awards 2013

Dear Colleagues:  Please find attached the Call for Nominations for the Division 28 APA awards for the upcoming 2013 meeting in Honolulu, Hawaii.  Feel free to share this announcement with others and post in your departments.  We look forward to receiving your nominations!
--
Dr. Sharon L. Walsh
Center on Drug and Alcohol Research
Department of Behavioral Science
Phone:  859-257-6485
Fax: 859-257-5232
email:  sharon.walsh@uky.edu

2012-11-27

[DIV28_ANNOUNCEMENT] Collaborative Perspectives on Addiction - Deadline Extended!

The Planning Committee for the first-ever Division 28/50 Annual Conference recognizes that the holiday season is a

busy one and has extended the deadline for Breakout Sessions to December 15, 2012. Please take a moment to consider

submitting a proposal AND please forward to colleagues to do the same. Presenting in the same program along with Dr. Shiffman

and Dr. Sullivan is quite an hour, and so will be presenting at the INAUGURAL conference! Don’t miss out!

 

 

 

 

 

 

Call for Proposals - Deadline– EXTENDED!

APA Division 28 and Division 50 invite you to submit a proposal for a Breakout Session or Poster Presentation at their first annual conference. Proposals that fit within the theme of "Biobehavioral RESEARCH & Implications for PRACTICE" will be considered for this first-annual endeavor.

Breakout Session: December 15 deadline, submit at www.tinyurl.com/2013CPABreakout
Poster Deadline: February 1 deadline, submit at www.tinyurl.com/2013CPAPoster

The official Call for Proposals is attached. The program committee (listed below) is available to answer any questions you have.

 


About the Conference

 

The theme for the 2013 conference is "Biobehavioral RESEARCH & Implications for PRACTICE"
>>Atlanta, Georgia / May 3-4, 2013
>>Registration will open December 2012
>>Two thought-provoking keynote sessions
>>Interactive environment for collaboration/networking
>>Several breakout session choices
>>Poster Sessions
>>Pre-conference in-depth workshops
>>Discounted rates for Early Career Psychologists
>>Student opportunities (discounted rates, special networking, etc)
>>You don't have to be a member of either or division or APA to attend the conference!


Meet the Keynoters

 

Saul Shiffman, PhD, is a world-renowned researcher in the fields of behavior change and relapse, self-management and self-control, field research methodology, statistical analysis, and addiction and dependence. Since 1991, he has been a professor in the departments of psychology and pharmaceutical science at the University of Pittsburgh. Dr. Shiffman has taught in the departments of psychology and psychiatry and behavioral medicine at various universities, including the University of South Florida, the University of Washington, and the University of Pittsburgh. Dr. Shiffman has authored or co-authored over 300 published papers on a variety of topics related to psychopharmacology, substance abuse, dependence, relapse, coping, and computerized assessments of behavior, and has presented widely in medical and scientific forums. A fellow of numerous professional societies (including APA Divisions 28 and 50), Dr. Shiffman was awarded the Society for Research on Nicotine and Tobacco’s Ovid Ferno Award for “ground breaking advances in clinical research.”

 

Edith V. Sullivan, PhD, is professor of psychiatry and behavioral sciences at Stanford University School of Medicine and a neuropsychologist who has pioneered the study of alcoholism-related brain injury on selective cognitive and motor function. She is the recipient of a Senior Scientist Research and Mentorship Award, a grant for international collaborations on alcoholism research, and an NIAAA MERIT award for studies of neural circuitry modification in alcoholism focused on frontocerebellar systems. Dr. Sullivan is a recipient of the Research Society on Alcoholism Distinguished Researcher Award and is author of more than 250 peer-reviewed papers and numerous chapters and reviews. Dr. Sullivan will present a keynote address on Saturday, May 4, titled “Alcoholism and the Brain: Road to Ruin and Path to Recovery.”


Call for Proposals

 

The Committee has issued a call for proposals for Breakout Sessions, and Posters. Deadlines are as follows:

  • Breakout Sessions: December 1, 2012
  • Posters: February 1, 2013

About the Venue

 

The beautiful W Hotel in Midtown Atlanta will be the venue for our First Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Hotel reservation information will be launched soon!


More Information?

 

Sara Jo Nixon, PhD, Conference Chair
Anthony Liguori, PhD, Conference Co-Chair
John Kelly, PhD, Sponsorship Co-Chair
Katie Witkiewitz, PhD, Sponsorship Co-Chair
Jennifer Buckman, PhD, Conference Treasurer
Chad Rummel, MEd, Registration and Hotel Accommodations (202-336-6121)

 

 

2012-11-21

[DIV28SUPER] Peter Dews


From: ACNP@ACNP.ORG
Sent: 11/20/2012 9:14:19 A.M. Eastern Standard Time
Subj: Death of a Colleague

 

 

American College of Neuropsychopharmacology

 

Dear Members,

 

It is with great sadness that we announce the death of Dr. Peter Dews on Friday, November 2nd.  Dr. Dews was a founder and Fellow Emeritus of the College.

 

Condolences may be sent to:

 

Grace Dews

99 Norumbega Road, Apt 231

Weston, MA, 02493

 

Thank you,

 

American College of Neuropsychopharmacology

5034A Thoroughbred Lane

Brentwood, TN 37027

(615) 324-2360 main

(615) 523-1715 fax

acnp@acnp.org

www.acnp.org

 

 

Confidentiality Notice: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain
confidential and privileged information.  Any unauthorized review,
use, disclosure or distribution is prohibited.  If you are not the
intended recipient, please contact the sender by reply
e-mail and destroy all copies of the original message.

2012-11-20

[DIV28SUPER] employment opportunities

Please note the below employment opportunities.

Thanks,

John

 

John M Roll, PhD

Associate Vice Provost--Scholarship and Graduate Studies

Division of Health Sciences

Washington State University

johnroll@wsu.edu

 

 

FACULTY POSITIONS

 

MEDICAL SCIENCES

 

Washington State University Division of Health Sciences, located on the Riverpoint campus in Spokane, invites applications for two tenure-track faculty positions at the rank of Assistant or Associate Professor and one at the rank of Professor in its new Medical Sciences section.  Applicants must have an earned doctorate degree in the basic, clinical, or translational medical sciences.  Successful candidates will be expected to maintain an active, extramurally funded research program, to mentor graduate students and fellows, and to teach in the professional and/or graduate curricula.  The successful candidate for the Professor position will additionally be expected to take a leadership role in rapidly expanding medical research in Spokane, including recruitment of faculty and programmatic development. 

 

Areas of research interest are open, but preference will be given to candidates completing research in the areas of planned growth in our program including molecular, cellular, physiological and systems biology approaches to: neurosciences/behavioral neurosciences (sleep, addictions, pain, anesthesia), senescence and immortality (stem cells, cancer, aging, regenerative medicine), microbiology (antimicrobial resistance, virology), and metabolic diseases (obesity, diabetes, renal and cardiovascular disease).

 

Washington State University is substantially building its research and graduate education capacity in the medical sciences. The Medical Sciences section also participates in preclinical medical education in the WWAMI program, which is a collaborative medical education program with the University of Washington School of Medicine.

 

Screening of applications will begin immediately and will continue until a suitable candidate is identified. To apply visit: www.wsujobs.com. Applications must include a current curriculum vitae and letter of application describing professional goals, research, and teaching experience. Before interviews commence four letters of reference will be required.

 

Contact Kim Noe, Administrative Manager, at knoe@wsu.edu or 509-358-7515 for questions, assistance with the application process or confidential expressions of interest.  Women and minorities are particularly encouraged to apply.  WASHINGTON STATE UNIVERSITY IS AN EQUAL OPPORTUNITY/AFFIRMATIVE ACTION EDUCATOR AND EMPLOYER.

 

2012-11-19

[DIV28_ANNOUNCEMENT] Div 28/50 Conference - DEC. 1 Deadline for Proposals

 

 

 

Call for Proposals - Deadline December 1

APA Division 28 and Division 50 invite you to submit a proposal for a Breakout Session or Poster Presentation at their first annual conference. Proposals that fit within the theme of "Biobehavioral RESEARCH & Implications for PRACTICE" will be considered for this first-annual endeavor.

Breakout Session: December 1 deadline, submit at www.tinyurl.com/2013CPABreakout
Poster Deadline: February 1 deadline, submit at www.tinyurl.com/2013CPAPoster

The official Call for Proposals is attached. The program committee (listed below) is available to answer any questions you have.

 


About the Conference

 

The theme for the 2013 conference is "Biobehavioral RESEARCH & Implications for PRACTICE"
>>Atlanta, Georgia / May 3-4, 2013
>>Registration will open December 2012
>>Two thought-provoking keynote sessions
>>Interactive environment for collaboration/networking
>>Several breakout session choices
>>Poster Sessions
>>Pre-conference in-depth workshops
>>Discounted rates for Early Career Psychologists
>>Student opportunities (discounted rates, special networking, etc)
>>You don't have to be a member of either or division or APA to attend the conference!


Meet the Keynoters

 

Saul Shiffman, PhD, is a world-renowned researcher in the fields of behavior change and relapse, self-management and self-control, field research methodology, statistical analysis, and addiction and dependence. Since 1991, he has been a professor in the departments of psychology and pharmaceutical science at the University of Pittsburgh. Dr. Shiffman has taught in the departments of psychology and psychiatry and behavioral medicine at various universities, including the University of South Florida, the University of Washington, and the University of Pittsburgh. Dr. Shiffman has authored or co-authored over 300 published papers on a variety of topics related to psychopharmacology, substance abuse, dependence, relapse, coping, and computerized assessments of behavior, and has presented widely in medical and scientific forums. A fellow of numerous professional societies (including APA Divisions 28 and 50), Dr. Shiffman was awarded the Society for Research on Nicotine and Tobacco’s Ovid Ferno Award for “ground-breaking advances in clinical research.”

 

Edith V. Sullivan, PhD, is professor of psychiatry and behavioral sciences at Stanford University School of Medicine and a neuropsychologist who has pioneered the study of alcoholism-related brain injury on selective cognitive and motor function. She is the recipient of a Senior Scientist Research and Mentorship Award, a grant for international collaborations on alcoholism research, and an NIAAA MERIT award for studies of neural circuitry modification in alcoholism focused on frontocerebellar systems. Dr. Sullivan is a recipient of the Research Society on Alcoholism Distinguished Researcher Award and is author of more than 250 peer-reviewed papers and numerous chapters and reviews. Dr. Sullivan will present a keynote address on Saturday, May 4, titled “Alcoholism and the Brain: Road to Ruin and Path to Recovery.”


Call for Proposals

 

The Committee has issued a call for proposals for Breakout Sessions and Posters. Deadlines are as follows:

  • Breakout Sessions: December 1, 2012
  • Posters: February 1, 2013

About the Venue

 

The beautiful W Hotel in Midtown Atlanta will be the venue for our First Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Hotel reservation information will be launched soon!


More Information?

 

Sara Jo Nixon, PhD, Conference Chair
Anthony Liguori, PhD, Conference Co-Chair
John Kelly, PhD, Sponsorship Co-Chair
Katie Witkiewitz, PhD, Sponsorship Co-Chair
Jennifer Buckman, PhD, Conference Treasurer
Chad Rummel, MEd, Registration and Hotel Accommodations (202-336-6121)

 

 

2012-11-16

[DIV28SUPER] [GRAYMAIL] NIDA Neuroscience Update, November 16, 2012

NIH Substance Use, Abuse, and Addiction Functional Integration

Today, Dr. Collins announced the Trans-NIH Substance Use, Abuse, and Addiction Functional Integration that will enhance the NIH Institute and Center (IC) collaborations around this important scientific and public health topic.

 

The Functional Integration is a collaborative framework that will draw on the past two years of collaboration among the NIH ICs on substance use, abuse, and addiction-related research. Already, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA) have made significant progress at integrating their intramural research programs in substance use, abuse, and addiction, including the appointment of a single Clinical Director for NIAAA and NIDA and the establishment of a joint genetics Intramural Research Program and a common Optogenetics lab. Additionally, they have initiated joint NIAAA and NIDA Council meetings.  By pooling resources and expertise, the Functional Integration will identify cross-cutting areas of research and confront challenges faced by multiple Institutes and Centers.

Over the past two years, we have also engaged in a serious effort to identify new opportunities in substance use, abuse, and addiction research and public health needs that are not currently being pursued across NIH.  We received exceptional feedback from stakeholders through our Scientific Strategic Plan Request for Information, public web meeting, and additional stakeholder meetings. The resulting draft plan will be a starting point for the Functional Integration leadership.

The NIAAA and NIDA Councils and the NCAB will meet on December 13 to discuss the Functional Integration. This is an open meeting and we will post the details within the next few days.

 

For draft strategic plan see http://www.nih.gov/blog/feedback/substance-abuse/new-opportunities.pdf

 

-----------------

 

TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

The National Institute on Drug Abuse (NIDA)  at the National Institutes of Health is an agency of the United States Department of Health and Human Services 

 

[DIV28SUPER] WCALB 2013 in Winter Park, Colorado: Second Call

 

The Winter Conference on Animal Learning and Behavior 
(http://www.american.edu/cas/psychology/wcalb/index.cfm) will convene in Winter Park, Colorado 
from Saturday evening, February 2, with departure Wednesday morning , February 6, 2013.  There
are a few remaining openings.  


KEYNOTE ADDRESS



Behavioral Dependence


Patrick M. Beardsley

Virginia Commonwealth University

&

Jack Bergman

Harvard Medical School

 

Abstract-- Pharmacological state (or context) and history can direct the expression of learned behavior (e.g., state dependent learning, drug discrimination).  Additionally, abrupt drug abstinence can control the expression of learned behavior, a phenomenon that can be defined as behavioral dependence.  In this presentation, examples of behavioral dependence will be described and contrasted with physical dependence.  In addition, the potential ramifications of behavioral dependence, as well as the implications for regulatory control of drugs, will be considered.

 

 

FOCUS SESSION

 

Pharmacological History and the Control and Expression of Learning and Behavior

 

Several of our focus Sessions have been published as special journal issues, and this years' will likely be also.  There is still room for another prepared participant or so in the Focus Session .  The format will be up to 25-minute presentations with a "research seminar" type discussion among participants.  Let me (sweiss@american.edu) know if you would like to join that session.  


In addition to the Keynote Addresses and the Focus Session, there are sessions determined by the interests of current year participants.  Graduate students are invited to present with the endorsement of their adviser.  Registration, four nights accommodations in a first-class shared condominium on the main street of Winter Park, an opening buffet reception and dinner in a fine restaurant is only $365/person. 


Please contact me (sweiss@american.edu) if you would like more information. 


Hope to see you in Winter Park,

 



Stan Weiss, Convener

Winter Conference on Animal Learning & Behavior

Department of Psychology

American University

Washington, DC 20016


 

 

 

 

[DIV28SUPER] Preliminary Description of Functional Integration of NIH SUAA Research Available

There’s now a barebones description of what the functional integration means posted at the NIH Feedback website

 

Best,

-geoff

 

 

Geoffrey K. Mumford, Ph.D. | Associate Executive Director for Government Relations

Science Directorate
American Psychological Association
750 First Street NE, Washington, DC 20002-4242
Tel: 202.336.6067 |  Fax: 202.336.6063

email: gmumford@apa.org | www.apa.org

   

 

P Most people consider the environment before printing their email.

 

 

 

 

 

 

 

 

 

 

 

 

[DIV28SUPER] FW: STATEMENT BY NIH DIRECTOR DR. FRANCIS COLLINS ON THE FUTURE OF SUBSTANCE USE, ABUSE, AND ADDICTION-RELATED RESEARCH AT NIH

FYI, some unexpected news from NIH.

Best,
-geoff

-----Original Message-----
From: NIH news releases and news items [mailto:NIHPRESS@LIST.NIH.GOV] On Behalf Of NIH OLIB (NIH/OD)
Sent: Friday, November 16, 2012 12:04 PM
To: NIHPRESS@LIST.NIH.GOV
Subject: STATEMENT BY NIH DIRECTOR DR. FRANCIS COLLINS ON THE FUTURE OF SUBSTANCE USE, ABUSE, AND ADDICTION-RELATED RESEARCH AT NIH

U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH NIH News NIH Office of the Director (OD) <http://www.nih.gov/icd/od/> For Immediate Release: Friday, November 16, 2012

CONTACT: NIH Office of Communications, 301-496-5787, <e-mail: nihnmb@mail.nih.gov>

STATEMENT BY NIH DIRECTOR DR. FRANCIS COLLINS ON THE FUTURE OF SUBSTANCE USE, ABUSE, AND ADDICTION-RELATED RESEARCH AT NIH

Two years ago, the National Institutes of Health's Scientific Management Review Board (SMRB) issued a report recommending that NIH move to establish a new institute focused on substance use, abuse, and addiction-related research to optimize NIH research in these areas. Another option strongly considered by the SMRB was the functional integration of existing research resources, rather than creation of a new institute.

After rigorous review and extensive consultation with stakeholders, I have concluded that it is more appropriate for NIH to pursue functional integration, rather than major structural reorganization, to advance substance use, abuse, and addiction-related research.  To that end, the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) will retain their institutional identities, while strengthening their ongoing efforts to work more closely with each other and with related research programs at other institutes and centers.

NIH has made significant progress in the last two years, coordinating research on substance use, abuse, and addiction across its various institutes and centers. This progress has bolstered my confidence that NIH can achieve the SMRB recommendations without structural reorganization. Moreover, given budget uncertainties, NIH must focus on advancing the entire biomedical research enterprise. The time, energy, and resources required for a major structural reorganization are not warranted, especially given that functional integration promises to achieve equivalent scientific and public health objectives. NIH will begin implementing this functional approach immediately, and develop metrics to ensure that we reach our goals to more effectively conduct and support research in these areas so vital to our nation's health.

The Office of the Director, the central office at NIH, is responsible for setting policy for NIH, which includes 27 Institutes and Centers. This involves planning, managing, and coordinating the programs and activities of all NIH components. The Office of the Director also includes program offices which are responsible for stimulating specific areas of research throughout NIH. Additional information is available at <http://www.nih.gov/icd/od/>.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <http://www.nih.gov>.

NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office

###

This NIH Director's Statement is available online at:
<http://www.nih.gov/about/director/11162012_statement_suaa.htm>.

To subscribe (or unsubscribe) from NIH News Release mailings, go to <http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.

If you subscribed via the NIH LISTSERV, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org